Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 20Lung Neoplasms 6Small Cell Lung Carcinoma 4Ovarian Neoplasms 4Neoplasms 4Colorectal Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Recurrence 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Breast Neoplasms 3Vulvar Neoplasms 2Vaginal Neoplasms 2Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Lymphoma, Non-Hodgkin 2Head and Neck Neoplasms 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Urothelial Cancer 1Urinary Bladder Diseases 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Thrombocytosis 1Testicular Neoplasms 1

Interventions

Ifosfamide 4Paclitaxel 3Thiotepa 2Peripheral Blood Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2Cisplatin 2Carboplatin 2Amplified Fragment Length Polymorphism Analysis 2tremelimumab 1thymoglobulin 1pembrolizumab 1palifosfamide lysine 1isophosphamide mustard 1etoposide phosphate 1durvalumab 1cabazitaxel 1Vinblastine 1Stem Cell Transplantation 1Rituximab 1Radiotherapy 1Polymerase Chain Reaction 1Mycophenolic Acid 1Moxifloxacin 1Microarray Analysis 1Melphalan 1In Situ Hybridization 1Immunologic Techniques 1Immunohistochemistry 1Immunoenzyme Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Testicular Neoplasms × durvalumab × Clear all
NCT03081923 2021-05-14

APACHE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Terminated
36 enrolled
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡